Beta-blockers for Oesophageal Varices (BOPPP)
Beta-blockers or Placebo for Primary Prophylaxis of Oesophageal Varices (BOPPP Trial). A Blinded, Multi-centre, Clinical Effectiveness and Cost-effectiveness Randomised Controlled Trial
Sponsor: Brighton and Sussex University Hospitals NHS Trust
This PHASE4 trial investigates Cirrhoses, Liver and Oesophageal Varices and is currently ongoing. Brighton and Sussex University Hospitals NHS Trust leads this study, which shows 7 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Jan 2025 — Present [monthly]
Unknown PHASE4
Status: Recruiting → Unknown
-
Sep 2024 — Jan 2025 [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Recruiting PHASE4
-
Nov 2019 — Jan 2021 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
▶ Show 2 earlier versions
-
Apr 2019 — Nov 2019 [monthly]
Not Yet Recruiting PHASE4
-
Jan 2019 — Apr 2019 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Brighton and Sussex University Hospitals NHS Trust
- Cardiff University
- Guy's and St Thomas' NHS Foundation Trust
- King's College Hospital NHS Trust
- King's College London
- St George's University Hospitals NHS Foundation Trust
For direct contact, visit the study record on ClinicalTrials.gov .